A combination of increased 2023 marriages, post-covid catch-up and the Year of the Dragon drives positivity around a lift in the 2024 Chinese birth rate, though market volumes for infant formula...

UBS has been positive on recovery and growth prospects for a2 Milk Co for quite a while and recently reiterated to the broker's clientele that Buy rating is supported by a forecast increase ...

With three listed Chinese infant milk formulas having recently reported, Bell Potter notes an average revenue growth decline of -20% year-on-year and an average contribution margin ...

Citi has explained its current rating on a2 Milk Co is based on the assumptions that it will be increasingly difficult for the company to achieve market share gains. The broker is looking ...